Johnson & Johnson to Invest More Than $1 Billion in Pennsylvania Cell Therapy Factory

robot
Abstract generation in progress

Johnson & Johnson plans to invest over $1 billion in a new cell therapy manufacturing facility in Montgomery County, Pennsylvania. This investment is part of the company’s broader commitment to inject $55 billion into the U.S. economy by early 2029. The new facility is expected to create more than 4,000 construction jobs and 500 biomanufacturing jobs.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin